NEW YORK, Aug. 23, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Genesis Healthcare, Inc. (NYSE:GEN), Maiden Holdings, Ltd. (NASDAQ:MHLD), Ichor Holdings, Ltd. (NASDAQ:ICHR), Armstrong World Industries, Inc. (NYSE:AWI), Rexnord Corporation (NYSE:RXN), and NovoCure Limited (NASDAQ:NVCR), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
GEN DOWNLOAD: http://Fundamental-Markets.com/register/?so=GEN
MHLD DOWNLOAD: http://Fundamental-Markets.com/register/?so=MHLD
ICHR DOWNLOAD: http://Fundamental-Markets.com/register/?so=ICHR
AWI DOWNLOAD: http://Fundamental-Markets.com/register/?so=AWI
RXN DOWNLOAD: http://Fundamental-Markets.com/register/?so=RXN
NVCR DOWNLOAD: http://Fundamental-Markets.com/register/?so=NVCR
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Genesis Healthcare, Inc. (NYSE:GEN), Maiden Holdings, Ltd. (NASDAQ:MHLD), Ichor Holdings, Ltd. (NASDAQ:ICHR), Armstrong World Industries, Inc. (NYSE:AWI), Rexnord Corporation (NYSE:RXN), and NovoCure Limited (NASDAQ:NVCR) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed August 21st, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
GENESIS HEALTHCARE, INC. (GEN) REPORT OVERVIEW
Genesis Healthcare's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Genesis Healthcare reported revenue of $1,272.36MM vs $1,341.28MM (down 5.14%) and basic earnings per share -$0.39 vs -$0.70. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Genesis Healthcare reported revenue of $5,373.74MM vs $5,732.43MM (down 6.26%) and basic earnings per share -$6.15 vs -$0.71. Genesis Healthcare is expected to report earnings on November 14th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.36. The estimated EPS forecast for the next fiscal year is -$1.26 and is expected to report on March 15th, 2019.
To read the full Genesis Healthcare, Inc. (GEN) report, download it here: http://Fundamental-Markets.com/register/?so=GEN
-----------------------------------------
MAIDEN HOLDINGS, LTD. (MHLD) REPORT OVERVIEW
Maiden's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Maiden reported revenue of $713.28MM vs $754.76MM (down 5.50%) and basic earnings per share -$0.07 vs -$0.26. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Maiden reported revenue of $2,921.15MM vs $2,731.63MM (up 6.94%) and basic earnings per share -$2.32 vs $0.20. Maiden is expected to report earnings on November 14th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.66. The estimated EPS forecast for the next fiscal year is $1.35 and is expected to report on February 27th, 2019.
To read the full Maiden Holdings, Ltd. (MHLD) report, download it here: http://Fundamental-Markets.com/register/?so=MHLD
-----------------------------------------
ICHOR HOLDINGS, LTD. (ICHR) REPORT OVERVIEW
Ichor's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Ichor reported revenue of $248.97MM vs $159.73MM (up 55.87%) and basic earnings per share $1.09 vs $0.40 (up 172.50%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Ichor reported revenue of $655.89MM vs $405.75MM (up 61.65%) and basic earnings per share $2.25 vs $0.92 (up 144.57%). Ichor is expected to report earnings on November 8th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.60. The estimated EPS forecast for the next fiscal year is $3.83 and is expected to report on February 6th, 2019.
To read the full Ichor Holdings, Ltd. (ICHR) report, download it here: http://Fundamental-Markets.com/register/?so=ICHR
-----------------------------------------
ARMSTRONG WORLD INDUSTRIES, INC. (AWI) REPORT OVERVIEW
Armstrong World Industries' Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Armstrong World Industries reported revenue of $248.60MM vs $225.60MM (up 10.20%) and basic earnings per share $0.90 vs $0.77 (up 16.88%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Armstrong World Industries reported revenue of $893.60MM vs $837.30MM (up 6.72%) and basic earnings per share $2.89 vs $1.88 (up 53.72%). Armstrong World Industries is expected to report earnings on October 29th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.86. The estimated EPS forecast for the next fiscal year is $4.40 and is expected to report on February 25th, 2019.
To read the full Armstrong World Industries, Inc. (AWI) report, download it here: http://Fundamental-Markets.com/register/?so=AWI
-----------------------------------------
REXNORD CORPORATION (RXN) REPORT OVERVIEW
Rexnord's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Rexnord reported revenue of $503.60MM vs $443.20MM (up 13.63%) and basic earnings per share -$0.06 vs $0.20. For the twelve months ended March 31st, 2018 vs March 31st, 2017, Rexnord reported revenue of $2,066.00MM vs $1,918.20MM (up 7.71%) and basic earnings per share $0.51 vs $0.65 (down 21.54%). Rexnord is expected to report earnings on November 7th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.32. The estimated EPS forecast for the next fiscal year is $1.96 and is expected to report on May 13th, 2019.
To read the full Rexnord Corporation (RXN) report, download it here: http://Fundamental-Markets.com/register/?so=RXN
-----------------------------------------
NOVOCURE LIMITED (NVCR) REPORT OVERVIEW
NovoCure's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, NovoCure reported revenue of $61.51MM vs $38.38MM (up 60.29%) and basic earnings per share -$0.17 vs -$0.24. For the twelve months ended December 31st, 2017 vs December 31st, 2016, NovoCure reported revenue of $177.03MM vs $82.89MM (up 113.57%) and basic earnings per share -$0.70 vs -$1.54. NovoCure is expected to report earnings on October 25th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.13. The estimated EPS forecast for the next fiscal year is $0.24 and is expected to report on February 28th, 2019.
To read the full NovoCure Limited (NVCR) report, download it here: http://Fundamental-Markets.com/register/?so=NVCR
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.